Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
CT ›
CTX101
Trademark search for:
CTX101
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-04-11 — Application filed
2018-04-19 — Application filed
2018-07-31 — Assigned to examiner
2018-08-07 — Priority action written
2018-08-07 — Priority action e-mailed
2018-08-07 — Notification of priority action e-mailed
2019-02-01 — Office action issued
2019-02-01 — Correspondence received in law office
2019-02-02 — Teas/email correspondence entered
2019-02-12 — Approved for pub - principal register
2019-03-01 — Assigned to lie
2019-03-20 — Notification of notice of publication e-mailed
2019-04-09 — Published for opposition
2019-04-09 — Official gazette publication confirmation e-mailed
2019-04-26 — Teas revoke/app/change addr of atty/dom rep received
2019-04-26 — Attorney/dom.rep.revoked and/or appointed
2019-06-04 — Noa e-mailed - sou required from applicant
2019-12-04 — Sou teas extension received
2019-12-04 — Sou extension 1 filed
2019-12-04 — Sou extension 1 granted
2019-12-06 — Notice of approval of extension request e-mailed
2020-06-01 — Sou teas extension received
2020-06-01 — Sou extension 2 filed
2020-06-01 — Sou extension 2 granted
2020-06-03 — Notice of approval of extension request e-mailed
2020-08-05 — Teas revoke/app/change addr of atty/dom rep received
2020-08-05 — Attorney/dom.rep.revoked and/or appointed
2020-08-05 — Teas change of domestic representatives address
2020-08-05 — Teas change of correspondence received
2020-11-11 — Sou teas extension received
2020-11-11 — Sou extension 3 filed
2020-11-11 — Sou extension 3 granted
2020-11-13 — Notice of approval of extension request e-mailed
2021-04-07 — Teas change of correspondence received
2021-04-07 — Applicant/correspondence changes (non-responsive) entered
2021-04-07 — Teas change of owner address received
2021-04-14 — Sou teas extension received
2021-04-14 — Sou extension 4 filed
2021-04-14 — Sou extension 4 granted
2021-04-16 — Notice of approval of extension request e-mailed
2022-01-10 — Application abandoned
2022-01-10 — Application abandoned
2022-01-10 — Final status recorded
Owner Information
CRISPR Therapeutics AG
CRISPR Therapeutics AG
Correspondent
Tiffany D. Gehrke Marshall Gerstein & Borun LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
